Clinical Trial Results:
            Effect of the plasma substitutes Gelofusine and Hydroxyethyl Starch 130/0.4 combined with lactated ringer's solution on the coagulation system
    
|     Summary | |
|     EudraCT number | 2011-000156-42 | 
|     Trial protocol | NL | 
|     Global completion date | 
                                    28 Oct 2011
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    15 Nov 2021
                             | 
|     First version publication date | 
                                    15 Nov 2021
                             | 
|     Other versions | |
|     Summary report(s) | Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: A randomized controlled trial June 2013Perfusion Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: A randomized controlled trial June 2013Perfusion | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
